Medindia
Medindia LOGIN REGISTER
Advertisement

Biocompare, Inc. Launches the Trends in Next Generation Sequencing Future Lab

Wednesday, March 15, 2017 Drug News
Advertisement
SOUTH SAN FRANCISCO, Calif., March 14, 2017 /PRNewswire/ -- Biocompare, a Division of CompareNetworks, Inc. and the leading product information resource for the life sciences, has launched the sixth in an ongoing series of digital immersive platforms called Future Lab: Trends in Next Gen Sequencing (http://www.biocompare.com/Future-Lab/Next-Gen-Sequencing/) . This interactive content hub, sponsored by Roche is designed to share the latest advances, trends and applications in analysis of the genome. In Future Lab, researchers will be able to learn and experience the ground-breaking information in the area of genome analysis, including whole genome sequencing, analysis of exomes, and transcriptome characterization as well as the latest tools and applications available to scientists.
Advertisement

There has been a positive response to the series of Future Lab contents hubs that have been launched.  The currently running Future Labs cover the areas of Protein Production, Immunodetection, Maintaining a Cell Culture Facility, Flow Cytometery and Liquid Handling and are all sponsored by leading tool-providers in the respective spaces. Biocompare has created Future Lab to assist researchers in learning about the latest trends and future opportunities in a diverse array of researcher fields.   
Advertisement

"We are really excited to have developed this platform to allow the 3 million scientists who visit Biocompare each year to be able to consume content in a much more engaging environment. This fully supports Biocompare's mission to educate scientists in the latest technology while providing the tool provider community a unique and novel way to engage with our audience," says Joan Boyce, VP & GM of Biocompare.

Future Lab brings together topical content and presents it in a focused and interactive environment to keep readers informed of the latest developments in research. The benefit of this is that as content gets added, users will be notified and come back over time to consume content. With all the available resources out there to users, it's the best way to push out content and see an immediate response.

"The creation of Future Lab is the next phase of growth and content development for Biocompare and we're excited about launching additional Future Labs in areas that are driving basic and translational research", says Mike Okimoto, PhD, Biocompare's co-founder and Chief Content Officer. "The next iteration of the platform will provide additional engagement opportunities and we look forward to rolling them out in the coming months".

Creating a community through content is what keeps users engaged and will in turn bring the scientific community closer.

About BiocompareBiocompare, a Division of CompareNetworks, Inc. is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines as in-depth knowledge of the life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information. Produced by scientists, Biocompare's mission is to provide free, time saving services to life science researchers, allowing scientists to find and learn about the technologies that drive discovery. Biocompare continually strives to serve the life science community by providing new and improved online services that facilitate product discovery and technology education. For more information, please visit www.biocompare.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biocompare-inc-launches-the-trends-in-next-generation-sequencing-future-lab-300423037.html

SOURCE Biocompare

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close